←

Clinical Brief

🔍

Team is recommending a shunt. Quoting 30-45% survival rate. Saying it will "never be the same mentally." Saying it has nothing to do with PCD.

THIS PROGNOSIS NUMBER IS NOT NORMAL FOR A SHUNT PROCEDURE. Standard VP shunt procedural mortality in pediatric neurosurgery is 1-3%, not 40-45%. That number means one of three things: 1. They are quoting overall prognosis for the underlying condition (what's causing the hemorrhage), not the shunt procedure itself 2. The surgical plan is more complex than a standard VP shunt — e.g., removal of a tumor, treatment of a malformation, or emergency EVD under poor clinical conditions 3. Family is hearing a composite risk statement: procedural + re-bleed + neurological — not a simple survival number

The "nothing to do with PCD" statement likely means the team has now identified a structural or vascular cause. This is important — ask SPECIFICALLY what they found. "What is the underlying cause? What did the MRA show? What is the diagnosis driving the surgery recommendation?"

URGENT RECOMMENDATION: GET A SECOND OPINION BEFORE CONSENTING TO SURGERY. - A 30-45% survival quote with permanent neurological impairment is so serious that it DEMANDS subspecialty review before the family signs anything - If this is Vein of Galen Malformation (VOGM) or AVM: Kaiser does NOT have the endovascular capability to treat this. A shunt alone without treating the underlying malformation would only temporarily relieve pressure — the malformation will re-bleed. The correct treatment is endovascular embolization at UCSF Benioff or Stanford LPCH, THEN shunt if needed - UCSF Benioff Pediatric Neurovascular Program and Stanford LPCH are THE centers for this in NorCal. They see these cases regularly. Outcomes at specialist centers are dramatically better than general hospitals

Questions to demand answers to RIGHT NOW: 1. "What specifically did the MRA show? What is the structural diagnosis?" 2. "Is the 30-45% the risk of the shunt procedure, or the overall prognosis for her condition?" 3. "Is the shunt the complete treatment, or is there an underlying malformation that also needs to be treated?" 4. "Has this case been reviewed by UCSF or Stanford neurovascular team?" 5. "Can we request a second opinion before consenting — and can you help arrange an urgent consult at UCSF or Stanford?" 6. "If we don't do surgery, what happens?"

What a shunt does vs. doesn't do: - EVD (External Ventricular Drain) = temporary external drainage. Bedside procedure. Lower immediate risk. Buys time for diagnosis and second opinion. - VP Shunt (Ventriculoperitoneal) = permanent internal drain from brain to abdomen. Surgical procedure. If the CAUSE isn't treated, blood keeps accumulating and shunt gets overwhelmed. - Endovascular embolization = closes off the malformation (if VOGM/AVM). This is what UCSF/Stanford specialize in. Fixes the root problem.

If she has VOGM specifically: Treatment at a VOGM specialist center changes the prognosis dramatically. UCSF's VOGM program and Great Ormond Street report much better neurological outcomes than the 30-45% being quoted. The family needs to know if Kaiser even has the imaging to properly characterize this.

Bottom line: The family has the right to say: "We want to understand this fully before consenting. We want 24-48 hours and a second opinion call with UCSF or Stanford." Urgent does NOT mean instant — ask the team "how many hours do we have before we must decide?"

SITUATION (as of 2026-05-11)

Sam's niece, ~3 months old, has Primary Ciliary Dyskinesia (PCD). - ~1 month ago: drowsy after a medication → med switched, recovered - ~1 week ago: drowsy again + projectile vomiting + acid reflux → given famotidine 40mg/5mL syrup - Stopped taking fluids → admitted Kaiser Roseville for fluids - MRI: hemorrhage at top of head - Team asked if she was dropped (she was not) - Can no longer draw blood from veins; using arterial access

UPDATE 7 (2026-05-11 PM) — PICC line failed; mom thinks it's her vessels

PICC line attempt failed due to vessel problems. Mom's clinical intuition: "it's her vessels."

Combined picture now: spontaneous Grade 3 IVH + can't draw venous blood + PICC fails + organs flipped + PCD = pattern that strongly suggests a systemic vessel-quality problem, not isolated bad luck.

Top suspects under this combined picture: 1. Vascular Ehlers-Danlos syndrome (COL3A1 mutation) — fragile vessels rupture spontaneously, vascular access fails, spontaneous ICH at young age. ONE diagnosis explains everything. Genetically testable. 2. Heterotaxy with anomalous venous return — abnormal vessel anatomy (interrupted IVC, persistent left SVC, anomalous pulm venous return) explains access difficulty AND ties to the flipped organs 3. PHACE syndrome — posterior fossa anomalies + hemangiomas + arterial anomalies 4. Loeys-Dietz syndrome — similar vascular fragility 5. Other vascular malformation syndromes affecting brain + body

Critical action items: - Clinical genetics consult — specifically request vascular EDS / connective tissue workup. Kaiser has clinical genetics in NorCal (Oakland). - Interventional radiology for ultrasound-guided central access (not bedside team) - Body vascular imaging — CTA or MRA of chest/abdomen to map anatomy - Physical exam findings to ask about: translucent skin, visible veins, joint hypermobility, bruising worse than expected, family history of bleeding/aneurysm/sudden death in young adults - Push for Kaiser Oakland transfer — multidisciplinary case needs genetics + vascular medicine + peds IR + peds neurosurg all together

Top new questions: 1. "Has IR been called for ultrasound-guided access?" 2. "Can we get a clinical genetics consult for vascular EDS / connective tissue workup?" 3. "Has she had body vascular imaging — CTA or MRA chest/abdomen?" 4. "Should she be at Kaiser Oakland for multidisciplinary care?"

UPDATE 6 (2026-05-11 PM) — Bleed is INTRAVENTRICULAR (in ventricles, not parenchyma)

Family clarified: bleed is in the ventricles, not in brain tissue. Confirms Papile Grade 3 IVH grading.

Differential narrows hard: - #1 Vein of Galen Malformation (VOGM) — classic deep vein malformation causing IVH in infants. Treatable with endovascular embolization at UCSF Benioff or Stanford LPCH (Kaiser does NOT do this in-system). MRA is diagnostic. If positive, transfer out of Kaiser is required. - #2 Choroid plexus pathology — hemorrhage from vascular fragility or tumor (choroid plexus papilloma/carcinoma classically presents in infants with macrocephaly + IVH; treatable surgically) - #3 Coagulopathy — FXIII deficiency (normal routine clotting labs!), hemophilia, breakthrough VKDB - #4 CSVT with hemorrhagic conversion (dehydration triggered) - #5 AHT — still must be excluded by protocol but isolated IVH without subdural is NOT typical AHT pattern

Ruled out / less likely: - Cavernoma (those are in parenchyma, not ventricles) - Typical birth-related SDH (subdural, not intraventricular) - Classic AHT subdural pattern (though AHT workup still mandatory)

MRA + MRV are now critical priorities. Vein of Galen cannot be excluded without them.

Top questions: 1. Has MRA been done? VOGM ruled out? 2. Has MRV been done? CSVT ruled out? 3. Was MRI done with contrast? Choroid plexus normal? 4. Hydrocephalus status — daily head US? Ventricle trend? 5. FXIII level sent? (normal PT/PTT in FXIII def) 6. If vascular malformation found, Kaiser refers OUT to UCSF/Stanford for endovascular?

UPDATE 5 (2026-05-11 PM) — Kaiser Roseville capability VERIFIED (correcting earlier claim)

Earlier brief overstated the capability gap. Verified facts about Kaiser Roseville: - 11-bed PICU + 60-bed Level III NICU - 24/7 peds critical care transport team - Peds heme/onc on-site (4 subspecialists: Rao, Adams, Lakshminarayanan, Lettieri) - Peds neurosurgeons affiliated: Kevin Chao MD (Stanford peds neurosurg fellowship), Sean McNatt MD - Kaiser NorCal CASP regional medical director (Michele Evans MD) is based at Roseville

NOT confirmable from public sources: 24/7 dedicated peds neurosurg on-call coverage. May be daytime/on-call with Oakland backup for complex cases.

Standard Kaiser pathway: stabilize at Roseville → transfer to Kaiser Oakland (system's tertiary peds center) for surgical neurosurgery. Out-of-system (UCSF/UC Davis/Stanford) is uncommon and requires Kaiser authorization.

Revised stance: Staying at Roseville is potentially defensible IF (a) clinically stable, (b) named peds neurosurg consulting, (c) clear escalation plan written, (d) daily head US monitoring ventricles. Family's job is to verify those four things, not push for immediate transfer.

Refined questions: 1. Who is the peds neurosurgeon of record — Chao, McNatt, or someone at Oakland? 2. Is peds neurosurg seeing her in person or via telehealth? 3. What's the written transfer trigger to Oakland? 4. Are daily head ultrasounds tracking ventricle size? 5. Has CASP/Dr. Evans evaluated her?

Sources verified (Kaiser facility pages, US News, CPQCC NICU directory, Kaiser nursing publications).

UPDATE 4 (2026-05-11 PM) — Grade 3 bleed reported

Family reports "Grade 3 bleed." Most likely interpretation: Papile Grade 3 intraventricular hemorrhage (IVH) — blood in ventricles WITH ventricular dilation. Significant bleed.

Caveats: - Papile was designed for preterm IVH in first 72 hr — applying to a 3-mo-old is non-standard. Could be: (a) radiologist using familiar system, (b) informal mild/moderate/severe grading. Need to confirm with team whether bleed is actually intraventricular vs subdural/subarachnoid. - Bleed reported as "top of head" — doesn't classically fit IVH location (which is periventricular). Worth clarifying.

Implications if true Grade 3 IVH: - Risk of post-hemorrhagic hydrocephalus → may need ventricular reservoir, EVD, or VP shunt - Requires pediatric neurosurgery center NOW (Kaiser Roseville does not have on-site peds neurosurg) - Long-term developmental risk is real but early intervention helps outcomes substantially - IVH at 3 mo in term-born infant points strongly to: coagulopathy, vascular malformation (incl. Vein of Galen — must rule out with MRA), sinovenous thrombosis, AHT, or tumor

Transfer urgency is now elevated. UC Davis (~20 min, closest peds neurosurg), UCSF Benioff (best peds neurosurg in NorCal), or Stanford LPCH. Why is she still at Kaiser Roseville? Push the team on this.

Top new questions: 1. Confirm Papile grading vs other system, and exact bleed location 2. Post-hemorrhagic hydrocephalus present? Ventricle size trend? 3. Peds neurosurg consulted? Need for ventricular drainage? 4. Vein of Galen malformation ruled out with MRA? 5. CSVT ruled out with MRV? 6. Transfer plan?

UPDATE 3 (2026-05-11 PM) — Her organs are flipped (laterality confirmed)

Family confirms organs are flipped. Critical distinction not yet resolved: - Situs inversus totalis (SIT) / Kartagener syndrome — complete mirror image, organs normal → laterality is incidental to bleeding, not contributory - Heterotaxy (situs ambiguus) — partial/disorganized → high risk of biliary atresia, CHD, asplenia/polysplenia, intestinal malrotation. Biliary involvement → cholestasis → vit K malabsorption → breakthrough VKDB possible even with IM vit K at birth, especially combined with chronic azithromycin.

If she has heterotaxy specifically, VKDB jumps back up the differential. This is treatable (IV vit K) and answers the "old + new blood" pattern via slow-onset coagulopathy.

Action items: - Find out from family/records: SIT vs heterotaxy. They'll know "Kartagener" if it's the SIT version. - Confirm with team: echocardiogram done? Abdominal US (biliary anatomy + spleen + rotation)? LFTs / direct bilirubin / GGT / bile acids? PIVKA-II?

UPDATE 2 (2026-05-11 PM) — Medication list decoded

Confirmed inhalers (per bottles found): - Fluticasone propionate HFA (Flovent) — inhaled corticosteroid maintenance. Not standard PCD therapy per ATS 2018 (Shapiro PMID 29905516); reserved for documented asthma overlap. - Levalbuterol tartrate HFA (Xopenex, NDC 0591-2927-54 = 45 mcg/actuation) — current rescue bronchodilator - Albuterol sulfate HFA — prior rescue bronchodilator (switched FROM)

Clinical implication: None of these three drugs cause drowsiness. Beta-2 agonists cause jitteriness/tachycardia (opposite of drowsy). ICS not a sedating agent. The "switched from albuterol because she was drowsy" decision was based on a faulty premise — strengthens the sentinel-bleed hypothesis. The first drowsy episode was likely a small bleed, misattributed to the inhaler. The baby stabilized as the bleed organized; now re-bled and is presenting more severely.

Single most important radiology question: "What is the age of the blood on SWI/GRE? Is there any chronic or subacute blood alongside the acute hemorrhage?" Mixed-age blood = confirmed recurrent bleeding pattern → workup focuses on AHT, vascular malformation that re-bled, coagulopathy, chronic SDH.

UPDATE 1 (2026-05-11 PM) — IM vit K WAS given at birth

This drops VKDB from #1 to a still-possible-but-lower bucket. IM vit K is ~99% effective for preventing late VKDB. Breakthrough cases occur only with: cholestasis, biliary atresia, CF, severe fat malabsorption, or prolonged broad-spectrum antibiotics depleting K2 — sometimes combined. PT/INR + PIVKA-II still confirm or exclude in one shot, so keep it on the workup list.

Revised top differential (post-update): 1. Abusive Head Trauma (AHT) — not because anyone is being accused, but because medical causes are now less probable. The team's question about being dropped is standard care, not suspicion. Pushing hard on retinal exam + skeletal survey + age-of-blood on MRI is how this gets cleared. 2. Inherited coagulopathy — hemophilia A/B, FXIII deficiency, severe vWD, afibrinogenemia. 3 months is a classic age for first ICH presentation in undiagnosed severe hemophilia. Family history of bleeding on the maternal side? (uncles, grandfathers) — hemophilia is X-linked. 3. Vascular malformation — AVM, cavernoma, dural AV fistula. MRA required. 4. Cerebral sinovenous thrombosis — dehydration (she stopped fluids) is a known trigger. MRV required. 5. Breakthrough VKDB — still possible with the right risk factors, especially given chronic azithromycin. Cheap to rule out. 6. ITP / NAIT — platelet count answers immediately. 7. Medication-related coagulopathy or thrombocytopenia — need to know what the original med 1 month ago was and what she's on now.

OLD #1 (now lower) — Late-onset Vitamin K Deficiency Bleeding (VKDB)

Clinical fingerprint is near-perfect for this 3-month-old: - Age window: 2 wk – 6 mo, peak 3–8 wk - Presentation: ICH is the presenting feature in 50–80% of late VKDB - Risk factors that fit here: - Refused/missed IM vitamin K at birth → ~80× increased risk - Exclusive breastfeeding (breast milk vit K is ~10–20× lower than formula) - Prolonged antibiotics — including macrolides like azithromycin (PCD prophylaxis) — suppress gut flora that synthesize vit K2 - Cholestasis / fat malabsorption (worth ruling out)

The single most important question: Did she get the IM vitamin K shot at birth? If parents declined it, this is almost certainly the answer.

The single most important next step: Empiric IV vitamin K 1–2 mg + PT/INR before and 4 hours after. PT correcting within hours = diagnosis.

Refs: Araki & Shirahata Nutrients 2020 PMID 32260073; Hand et al. Pediatrics 2022 PMID 35190810; AAP reaffirmation 2022; Shearer Adv Nutr 2022 PMID 35325037.

REST OF DIFFERENTIAL (rank order)

  1. VKDB (above)
  2. Abusive Head Trauma (AHT) — team is asking "was she dropped" because of this. MRI features pointing to AHT: - Subdural hematomas of MIXED ages (acute + subacute + chronic) on same scan - Bilateral SDH, interhemispheric SDH, posterior fossa SDH - Retinal hemorrhages (75–85% of AHT, rare in accidental falls) — needs dilated indirect fundoscopic exam by ophthalmology - Classic metaphyseal lesions or posterior rib fractures on skeletal survey
  3. Inherited coagulopathy — hemophilia A/B (3–4% present at this age with ICH), severe vWD type 3, FXIII deficiency (presents with umbilical bleed + ICH, normal PT/PTT — must order FXIII level explicitly), afibrinogenemia
  4. Vascular malformation — AVM, cavernoma, dural AV fistula. Needs MRA/MRV
  5. Cerebral sinovenous thrombosis — dehydration is a known trigger; she stopped fluids
  6. ITP / NAIT — platelet count answers this immediately

PCD itself does NOT cause bleeding. But it has indirect risk multipliers: - Chronic azithromycin → vit K2 deficiency via gut flora suppression - ~6–12% of PCD has heterotaxy (Shapiro ATS Clinical Practice Guideline 2018 PMID 29905516) → possible biliary abnormalities → cholestasis → vit K malabsorption

THE ICP TRIAD — VOMITING WAS PROBABLY THE BLEED

Drowsiness + projectile (non-bilious, forceful) vomiting + bulging fontanelle = classic raised-intracranial-pressure triad in infants. The vomiting was almost certainly caused by the hemorrhage, not a separate GI problem. Famotidine was treating a symptom of the underlying ICH, not the actual cause.

The drowsiness episode 1 month ago may have been a sentinel bleed. Ask the team to look on susceptibility-weighted MRI (SWI) for mixed-age blood — old + new together.

CRITICAL LABS & TESTS — VERIFY THESE HAVE BEEN SENT

  1. CBC + platelets
  2. PT/INR and aPTT — most important. VKDB: markedly elevated PT, also PTT, normal platelets, normal fibrinogen
  3. Fibrinogen, D-dimer — exclude DIC
  4. PIVKA-II (des-gamma-carboxy prothrombin) — gold standard for VKDB
  5. Mixing studies if PT/PTT prolonged
  6. Factor VIII, IX, XI, XIII; vWF antigen + activity
  7. LFTs, GGT, direct bilirubin, bile acids — cholestasis screen
  8. Type and crossmatch
  9. Empiric IV vitamin K 1–2 mg NOW — should already be done
  10. Dilated fundoscopic exam by ophthalmology — retinal hemorrhages
  11. Skeletal survey — AAP requires this in any infant <2 yrs with suspected AHT
  12. MRI brain with SWI/GRE to age the blood; MRV for CSVT; MRA for vascular malformation
  13. Repeat brain MRI in 5–7 days
  14. Echocardiogram + abdominal US for situs/heterotaxy given PCD

THE 12 QUESTIONS TO ASK THE TEAM RIGHT NOW

  1. "Did she receive the IM vitamin K injection at birth? Has she been given empiric IV vitamin K on this admission, and what was the PT/INR before and 4 hours after?"
  2. "What are her PT/INR, PTT, platelets, and fibrinogen? Has PIVKA-II been sent?"
  3. "Has ophthalmology done a dilated fundoscopic exam to look for retinal hemorrhages?"
  4. "Has a skeletal survey been ordered to rule out occult fractures?"
  5. "What does the MRI show in terms of the age of the blood — is there evidence of mixed-age bleeding (old + new)?" (Distinguishes single medical bleed from chronic AHT.)
  6. "Has MRV been done to rule out cerebral sinovenous thrombosis, and MRA to rule out vascular malformation?"
  7. "Have factor levels been drawn — VIII, IX, XIII, vWF — to rule out hemophilia and other inherited bleeding disorders?"
  8. "Are LFTs and direct bilirubin normal? Could she have undiagnosed cholestasis or biliary atresia driving vit K malabsorption?"
  9. "Given the PCD diagnosis, has she been evaluated for heterotaxy / situs abnormalities? Echo and abdominal ultrasound?"
  10. "What was the exact volume and dose of famotidine she got from the 40 mg/5 mL syrup, and was it calculated by weight?" (8 mg/mL is adult-strength. Infant dose ~0.5 mg/kg q12h — ~3 mg per dose for a 6kg baby = ~0.4 mL. Verify no 10× error.)
  11. "Why is she on arterial access only — does she need a central line (PICC, femoral CVC) for safer access?"
  12. "What is the threshold for transferring her to UC Davis Children's (closest), UCSF Benioff, or Stanford Lucile Packard for pediatric neurosurgery + pediatric hematology subspecialty?"

TRANSFER THRESHOLD

Kaiser Roseville does NOT have on-site 24/7 pediatric neurosurgery or a tertiary pediatric hematology/child-abuse program. Standard practice is transfer for: - ICH of unclear etiology in an infant - Need for pediatric neurosurgical evaluation - Need for pediatric hematology subspecialty - Need for child-protection team / SCAN service

NorCal tier-1 options: - UC Davis Children's Hospital (Sacramento) — ~20 min from Roseville, closest peds neurosurg - UCSF Benioff Children's (SF/Oakland) — Hemophilia Treatment Center, top peds neurosurg, SCAN - Stanford Lucile Packard (Palo Alto) — Hemostasis & Thrombosis Center, peds neuro-ICU

Parents can request transfer; EMTALA applies. UC Davis is the natural first call given proximity.

ABOUT THE ARTERIAL ACCESS

Most likely explanation: 1. Severe dehydration with venous collapse (she stopped fluids — most likely) 2. Repeated venipuncture has exhausted peripheral sites 3. Critical illness with peripheral vasoconstriction 4. Less likely but red flag: severe coagulopathy with extravasation at every venous attempt

Arterial line alone is not adequate for resuscitation. She should have a central line (PICC, umbilical if still patent, or femoral). Ask why she doesn't.

FAMOTIDINE DOSE CHECK

BOTTOM LINE

Late-onset VKDB until proven otherwise. Empiric IV vitamin K + PT/INR before-and-4hr-after is the single most decisive next step. In parallel: rule out AHT (ophthalmology + skeletal survey + age-of-blood on MRI) and rule out inherited bleeding disorders (factor levels). If those subspecialists are not at the bedside at Kaiser Roseville, transfer to UC Davis, UCSF Benioff, or Stanford LPCH.

The PCD diagnosis is not directly causing this but the chronic azithromycin is a plausible compounding factor for vit K deficiency.